dronabinol has been researched along with Epilepsies, Myoclonic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, C; Devinsky, O; Friedman, D; Hamlin, T; Marmanillo, A; Ryan, D; Todd, G; Wilken, P | 1 |
| Cross, HJ; Pietrafusa, N; Specchio, N | 1 |
| Chang-Douglass, S; Mulvihill, C; Pilling, S | 1 |
| Anderson, LL; Arnold, JC; Low, IK; McGregor, IS | 1 |
| Burggren, AC; Ginder, N; London, ED; Shirazi, A | 1 |
| McCall, C | 1 |
| ElSohly, MA; Fasinu, PS; Phillips, S; Walker, LA | 1 |
| Devinsky, O; Gloss, D; O'Connell, BK | 1 |
3 review(s) available for dronabinol and Epilepsies, Myoclonic
| Article | Year |
|---|---|
Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.
Topics: Age Factors; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Brain; Cannabidiol; Cognition; Dronabinol; Endocannabinoids; Epilepsies, Myoclonic; Humans; Infant; Lennox Gastaut Syndrome; Medical Marijuana; Organ Size; Spasms, Infantile | 2019 |
Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
Topics: Cannabidiol; Dronabinol; Endocannabinoids; Epilepsies, Myoclonic; Epilepsy; Humans; Lennox Gastaut Syndrome; Receptors, Cannabinoid | 2016 |
Cannabinoids in treatment-resistant epilepsy: A review.
Topics: Adult; Anticonvulsants; Cannabidiol; Cannabinoids; Child; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Young Adult | 2017 |
5 other study(ies) available for dronabinol and Epilepsies, Myoclonic
| Article | Year |
|---|---|
Observational study of medical marijuana as a treatment for treatment-resistant epilepsies.
Topics: Adolescent; Adult; Anticonvulsants; Cannabidiol; Child; Dronabinol; Epilepsies, Myoclonic; Epilepsy; Humans; Medical Marijuana; Middle Aged; Seizures; Young Adult | 2022 |
Source of cannabinoids: what is available, what is used, and where does it come from?
Topics: Anticonvulsants; Cannabidiol; Cannabinoids; Child; Child, Preschool; Dronabinol; Drug Combinations; Epilepsies, Myoclonic; Epilepsy; Humans; Lennox Gastaut Syndrome; Plant Extracts; Seizures | 2020 |
Cannabis-based medicinal products: summary of NICE guidance.
Topics: Antiemetics; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Decision Making, Shared; Dronabinol; Drug and Narcotic Control; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Nausea; Needs Assessment; Physicians, Primary Care; Practice Guidelines as Topic; Specialization; United Kingdom; Vomiting | 2020 |
Interactions between cannabidiol and Δ
Topics: Animals; Cannabidiol; Dronabinol; Epilepsies, Myoclonic; Mice; Mice, Inbred C57BL; NAV1.1 Voltage-Gated Sodium Channel; Seizures | 2020 |
Momentum grows for medical use of cannabis.
Topics: Child; Clinical Trials as Topic; Dronabinol; Epilepsies, Myoclonic; Female; Humans; Medical Marijuana; United States | 2015 |